| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6054534 | Oral Oncology | 2016 | 6 Pages |
Abstract
Panitumumab and paclitaxel is an active combination, providing promising outcomes with preservation of the QoL and a favorable safety profile. (EudraCT: 2010-018898-37; NCT01264328).
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Elvira del Barco Morillo, Ricard MesÃa, Juan Carlos Adansa Klain, Silvia Vázquez Fernández, Joaquina MartÃnez-Galán, Miguel Pastor Borgoñon, Cyntia González-Rivas, Javier Caballero Daroqui, Alfonso Berrocal, Javier MartÃnez-Trufero, Ruth Vera,